Myovant Sciences
Why Robinhood?
You can watch MYOV and buy or sell other stocks, ETFs, and their options commission-free!About MYOV
Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids.
MYOV Key Statistics
Stock Snapshot
The current Myovant Sciences(MYOV) stock price is $26.98, with a market capitalization of 2.62B. The stock trades at a price-to-earnings (P/E) ratio of -14.05.
Myovant Sciences(MYOV) stock opened on 2026-02-23 at —. The price climbed to — and dipped to —.
The Myovant Sciences(MYOV)'s current trading volume is 0, compared to an average daily volume of 1.68M.
During the past year, Myovant Sciences(MYOV) stock moved between $7.67 at its lowest and $27.06 at its peak.
During the past year, Myovant Sciences(MYOV) stock moved between $7.67 at its lowest and $27.06 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.